30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Flynn Daniel Lee

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 66% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Flynn Daniel Lee's trades of Deciphera Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-21 2023-06-16
S Sale
45,129 +45.9%
320.80
US$1,452,964 		45,129 +45.9% 320.80 US$1,452,964
2023-02-17 2023-02-16
S Sale
7,479 +10.9%
164.09
US$1,757,665 		7,479 +10.9% 164.09 US$1,757,665
2023-01-19 2023-01-17
S Sale
71,245 -15.5%
199.51
US$1,829,521 		71,245 -15.5% 199.51 US$1,829,521
2022-06-21 2022-06-16
S Sale
1,768 -3.7%
10.75
US$19,006 		1,768 -3.7% 10.75 US$19,006
2022-02-18 2022-02-16
S Sale
1,366 -2.8%
9.05
US$12,362 		1,366 -2.8% 9.05 US$12,362
2021-02-18 2021-02-16
S Sale
508 -7.2%
48.87
US$24,826 		508 -7.2% 48.87 US$24,826
2019-10-30 2019-10-28
PlS Planned sale
29,820 -54.9%
40.00
US$1,192,800 		29,820 -54.9% 40.00 US$1,192,800
2019-01-18 2019-01-16
PlS Planned sale
152,629 -100.0%
26.00
US$3,968,354 		152,629 -100.0% 26.00 US$3,968,354
2019-01-15 2019-01-11
PlS Planned sale
300 -100.0%
26.00
US$7,800 		300 -100.0% 26.00 US$7,800